Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/1992
10/28/1992EP0510318A1 Compositions for the topical treatment of burns
10/27/1992US5158981 Skin disorders, deodorants
10/27/1992US5158977 Antioxidant; preventive treatment of cutaneous inflammations and allergies
10/27/1992US5158975 Use of stearidonic acid
10/27/1992US5158773 Retinoid esters
10/27/1992CA2066931A1 Bfgf mutein and its production
10/27/1992CA1309557C Leukotriene antagonists
10/24/1992CA2066509A1 N-hydroxy-n-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas
10/24/1992CA2066508A1 N-hydroxy-n-(3-(2-(halophenylthio)phenyl) prop-2-enyl)-ureas as lipoxygenase inhibitors
10/21/1992EP0509762A1 Indole and dihydroquinoline potassium channel openers
10/21/1992EP0509761A1 Transdermal composition containing selegiline
10/21/1992EP0509753A1 Semi-synthetic immunosuppressive macrolides
10/20/1992WO1992018155A1 Bradykinin type peptides
10/20/1992CA1309025C Topical preparation containing ofloxacin
10/19/1992CA2066138A1 Semi-synthetic immunosuppressive macrolides
10/16/1992CA2065499A1 Indole and dihydroquinoline potassium channel openers
10/16/1992CA2065134A1 Transdermal composition
10/15/1992WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis
10/15/1992WO1992017206A1 Wound healing
10/15/1992WO1992017172A1 Disubstituted naphthalenes
10/15/1992WO1992017160A1 Use of sphingolipids in the preparation of a cosmetic or dermapharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
10/15/1992WO1992017065A2 Method of inhibiting fibrosis
10/15/1992CA2107371A1 Method of inhibiting fibrosis
10/14/1992EP0508792A1 Anti-tumor and anti-psoriatic agents
10/14/1992EP0508690A1 Tetronic and thiotetronic acid derivatives
10/14/1992CN1065270A Process for preparation of enantiomerically pure thienopyran derivatives
10/14/1992CN1065264A Stereoselective preparation of substituted piperidines
10/13/1992US5155217 Ongogene encoding polypeptide having growth factor activity
10/13/1992US5155125 Orally Administering; having an aldose reductase inhibitory activity
10/13/1992US5155038 Administering to mammals
10/13/1992CA2065689A1 Pharmaceutical composition and process for the preparation thereof
10/13/1992CA2065228A1 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors
10/12/1992WO1992018507A1 Anti-tumor and anti-psoriatic agents
10/12/1992CA2108146A1 Anti-tumor and anti-psoriatic agents
10/11/1992WO1992018098A1 Antimicrobial compositions useful for medical applications
10/07/1992EP0507190A1 Compositions with physiological cooling effect and active compounds suitable for such compositions
10/07/1992CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use
10/06/1992US5153174 Polymer mixtures useful in skin care
10/06/1992CA2064918A1 Compositions having a physiological cooling effect and active compounds suitable for these compositions
10/04/1992CA2064931A1 Extracts of alchemilla vulgaris, their preparation and their applications
10/01/1992WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992WO1992016216A1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them
09/1992
09/30/1992EP0506326A2 Diequitorially bound beta 1-4 polyuronates and use of same for cytokine stimulation
09/30/1992EP0506197A1 Topical preparation containing a suspension of solid lipid particles
09/30/1992EP0505434A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them
09/29/1992US5151534 Antiallergens, antiinflammatory agents or skin disorders
09/27/1992WO1992017471A1 Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity
09/27/1992WO1992017449A1 Stereoselective preparation of substituted piperidines
09/27/1992WO1992017426A2 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
09/27/1992CA2105379A1 Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity
09/27/1992CA2105158A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
09/23/1992EP0504862A1 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of C3-7 alpha-hydroxy carboxylic acid
09/23/1992EP0504695A1 New carboxamides, their preparation and pharmaceutical compositions containing them
09/23/1992EP0504403A1 Topical therapeutic preparation
09/23/1992EP0504335A1 A fibronectin binding peptide
09/23/1992EP0504236A1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions.
09/22/1992WO1992016544A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
09/22/1992US5149860 Carbamate derivatives
09/22/1992US5149705 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
09/22/1992CA2102689A1 Novel caffeic acid derivative, oraposide, and cosmetic or pharmaceutic, especially dermatological, composition containing it
09/22/1992CA2061662A1 Novel carboxylic amides
09/19/1992CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
09/17/1992WO1992015314A1 Pharmaceutical compositions for the treatment of skin disorders
09/17/1992WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
09/17/1992WO1992013553A3 Method and agents for promoting wound healing
09/17/1992DE4108351A1 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel New leukotriene b (Down Arrow) 4 (down arrow) derivatives, process for their production and their use as drug
09/17/1992CA2105073A1 Pharmaceutical compositions for the treatment of skin disorders
09/16/1992EP0504017A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them
09/16/1992EP0503988A1 Compositions to treat onychomycoses
09/16/1992EP0503887A2 Promotion of wound-healing with 15-keto-prostaglandin compounds
09/16/1992EP0503852A1 Soap compounded with vitamin B1-containing garlic extract
09/16/1992EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3
09/15/1992US5147859 Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them
09/15/1992US5147637 Administering an anti-infective agent and a monoclonal antibody to reduce inflammation caused by meningitis or encephalitis
09/15/1992CA1307530C Carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
09/15/1992CA1307529C Aminoacyllabdanes, a process and intermediates for their preparation and their use as medicaments
09/15/1992CA1307524C Dispersions of chitin and product therefrom
09/15/1992CA1307467C Composition for the treatment of acne and seborrhea an hydroperoxide as active ingredient
09/13/1992WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3
09/13/1992WO1992016504A1 New leukotriene b4 derivatives, method for preparing them and their use as drugs
09/13/1992CA2082818A1 Leukotriene b4 derivatives, method for preparing them and their use as drugs
09/09/1992EP0502502A1 Topical composition containing ketoprofen lysinate
09/09/1992CN1064275A Imidazopyridine paf/h1 antagonists
09/09/1992CA2062465A1 Soap compounded with vitamin b1-containing garlic extract
09/09/1992CA2062407A1 Benzopirene derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them
09/08/1992US5145868 Alkanophenones useful for treating allergies
09/08/1992US5145685 Skin treatment method and composition
09/08/1992US5145676 Method and agents for promoting wound healing
09/08/1992CA1307288C Chemical compounds
09/08/1992CA1307255C Process for producing a huminate fraction
09/03/1992WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
09/02/1992EP0501579A1 Naphthalene lactones as inhibitors of leukotriene biosynthesis
09/02/1992EP0501205A1 Antiphlogistic means
09/02/1992EP0500807A1 Tissue moisturizing composition and method
09/02/1992EP0500773A1 Non-glycosylated fgf-4 and compositions containing the same
09/02/1992CN1064080A Peptide compounds, process for preparation thereof and pharmaceutical composition comprising same
09/02/1992CN1064079A Steroids
09/02/1992CN1064078A Steroid esters
09/01/1992US5144081 Sunscreen agents
09/01/1992US5143829 One of the alanine residues following N-terminal methionine is removed